Altered expression of ZO-1 and ZO-2 in Sertoli cells and loss of blood-testis barrier integrity in testicular carcinoma in situ

被引:65
作者
Fink, Cornelia
Weigel, Roswitha
Hembes, Tanja
Lauke-Wettwer, Heidrun
Kliesch, Sabine
Bergmann, Martin
Brehm, Ralph H.
机构
[1] Univ Giessen, Inst Vet Anat, D-35392 Giessen, Germany
[2] Univ Hamburg Hosp, Inst Anat 1, Eppendorf, Germany
[3] Univ Munster, Dept Urol, D-4400 Munster, Germany
来源
NEOPLASIA | 2006年 / 8卷 / 12期
关键词
blood-testis barrier; carcinoma in situ; ZO-1; ZO-2; lanthanum tracer;
D O I
10.1593/neo.06559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinoma in situ (CIS) is the noninvasive precursor of most human testicular germ cell tumors. In normal seminiferous epithelium, specialized tight junctions between Sertoli cells constitute the major component of the blood-testis barrier. Sertoli cells associated with CIS exhibit impaired maturation status, but their functional significance remains unknown. The aim was to determine whether the blood-testis barrier is morphologically and/or functionally altered. We investigated the expression and distribution pattern of the tight junction proteins zonula occludens (ZO) 1 and 2 in normal seminiferous tubules compared to tubules showing CIS. In normal tubules, ZO-1 and ZO-2 immuno-staining was observed at the blood-testis barrier region of adjacent Sertoli cells. Within CIS tubules, ZO-1 and ZO-2 immunoreactivity was reduced at the blood-testis barrier region, but spread to stain the Sertoli cell cytoplasm. Western blot analysis confirmed ZO-1 and ZO-2, and their respective mRNA were shown by RT-PCR. Additionally, we assessed the functional integrity of the blood-testis barrier by lanthanum tracer study. Lanthanum permeated tight junctions in CIS tubules, indicating disruption of the blood-testis barrier. In conclusion, Sertoli cells associated with CIS show an altered distribution of ZO-1 and ZO-2 and lose their blood-testis barrier function.
引用
收藏
页码:1019 / 1027
页数:9
相关论文
共 67 条
[1]  
[Anonymous], ANDROLOGY CLIN
[2]  
BERGMANN M, 1989, CELL TISSUE RES, V256, P183
[3]   Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon [J].
Bergstrom, R ;
Adami, HO ;
Mohner, M ;
Zatonski, W ;
Storm, H ;
Ekbom, A ;
Tretli, S ;
Teppo, L ;
Akre, O ;
Hakulinen, T .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (11) :727-733
[4]   Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality [J].
Bray, Freddie ;
Richiardi, Lorenzo ;
Ekbom, Anders ;
Pukkala, Eero ;
Cuninkova, Martina ;
Moller, Henrik .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) :3099-3111
[5]   Altered expression of connexins 26 and 43 in Sertoli cells in seminiferous tubules infiltrated with carcinoma-in-situ or seminoma [J].
Brehm, R ;
Marks, A ;
Rey, R ;
Kliesch, S ;
Bergmann, M ;
Steger, K .
JOURNAL OF PATHOLOGY, 2002, 197 (05) :647-653
[6]   Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in sertoli cells and germ cells [J].
Brehm, Ralph ;
Ruettinger, Christina ;
Fischer, Petra ;
Gashaw, Isabella ;
Winterhager, Elke ;
Kliesch, Sabine ;
Bohle, Rainer M. ;
Steger, Klaus ;
Bergmann, Martin .
NEOPLASIA, 2006, 8 (06) :499-509
[7]   DEVELOPMENT OF SERTOLI-CELL JUNCTIONAL SPECIALIZATIONS AND THE DISTRIBUTION OF THE TIGHT-JUNCTION-ASSOCIATED PROTEIN ZO-1 IN THE MOUSE TESTIS [J].
BYERS, S ;
GRAHAM, R ;
DAI, HN ;
HOXTER, B .
AMERICAN JOURNAL OF ANATOMY, 1991, 191 (01) :35-47
[8]  
Byers SW, 1992, TIGHT JUNCTIONS, P279
[9]  
Chung SSW, 1999, J CELL PHYSIOL, V181, P258, DOI 10.1002/(SICI)1097-4652(199911)181:2<258::AID-JCP8>3.0.CO
[10]  
2-Q